Finding new receptors that sense changes in fluid balance in tiny worms.
Identification of novel osmosensing receptors in C. elegans
This study is looking at how tiny worms can sense changes in fluid levels, which is important for keeping cells balanced, and by understanding this, researchers hope to find new ways to help people with conditions related to fluid imbalances.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Oklahoma Hlth Sciences Ctr NIH-funded |
| Lab location | 1 site (Oklahoma City, United States) |
| Project ID | NIH-11042819 on NIH RePORTER |
What this research studies
This research investigates how certain receptors in the tiny worm C. elegans can detect changes in osmolarity, which is crucial for maintaining fluid balance in cells. By using advanced genetic tools and monitoring neural activity, the researchers aim to identify these osmosensing receptors. Understanding these mechanisms could provide insights into how similar processes work in humans, potentially leading to new treatments for conditions caused by fluid imbalances. The study leverages the unique characteristics of C. elegans, including its rapid life cycle and genetic manipulability.
Who could benefit from this research
Good fit: Ideal candidates for benefiting from this research include individuals suffering from conditions that cause fluid imbalance, such as kidney disease or diabetes.
Not a fit: Patients with conditions unrelated to osmolarity or fluid balance may not receive any benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new therapeutic strategies for managing conditions related to fluid imbalance in humans.
How similar studies have performed: While the approach of identifying osmosensors in C. elegans is innovative, similar studies in other organisms have shown promise in understanding osmolarity regulation.
Where this research is happening
Oklahoma City, United States
- University of Oklahoma Hlth Sciences Ctr — Oklahoma City, United States (Active)
Researchers
- Principal investigator: Zhang, Xinxing — University of Oklahoma Hlth Sciences Ctr
- Study coordinator: Zhang, Xinxing
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.